HR 2882 - Further Consolidation Appropriations- Support for critical government programs remaining operational and available.
HR 4366 - Consolidated Appropriations Act of FY 2024 and other Extensions Act - Support for critical government programs remaining operational and available.
H.R. 7024 - Tax Relief for American Families and Workers Act of 2024 - Issues related to the R&D tax credit and other tax treatments to support job creation and innovation.
Regulations, guidance and other activity related to artificial intelligence and health care.
Regulations, guidance and other activity related to women's health care and research.
Rules and regulations regarding the availability of diagnostic treatments and testing related to neurological disorders.
S. 1544 - Facilitating Innovative Nuclear Diagnostics Act of 2023 - A bill to ensure that there is equitable and accessible coverage of radio-diagnostic treatments to detect diseases like Alzheimer's and Parkinson's across the country.
Issues related to ensuring access to real time hospital data during national emergencies and pandemics for physicians and relevant health care personnel.
Issues related to ensuring rural, underserved and other communities access to certain procedures and related drugs used to diagnose neurological disorders, such as Parkinson's disease.
Issues related to women's health specific to access to imaging and other procedures used to assess the health of breasts and other organs.
Issues related to ensuring access to cancer screening and treatments.
Duration: January 21, 2011
to
January 6, 2014
General Issues: Health Issues , Medicare/Medicaid , Insurance
Spending: about $1,620,600 (But it's complicated. Here's why.)
It can be tricky to figure out how much an organization spent on a particular lobbying engagement. The law only requires lobbyists to report the amount they were paid for federal lobbying each quarter rounded to the nearest $10,000—and if it's less than $3,000 in a given quarter (or less than $13,000 for organizations with in-house lobbyists), they don't have to disclose it at all. Plus, some organizations include spending that doesn’t belong in the report—for instance, money spent lobbying state governments or other legal work.
Agencies lobbied since 2011: House of Representatives, U.S. Senate, Centers For Medicare and Medicaid Services (CMS), Office of Science & Technology Policy (OSTP), Health & Human Services - Dept of (HHS), Office of the Vice President of the United States, Office of Management & Budget (OMB), Centers For Medicare and Medicaid Services (CMS), U.S. Senate,, Health & Human Services - Dept of (HHS)
Lobbyists
Lobbyists named here were listed on a filing related to this lobbying engagement. They may not be working on it now. Occasionally, a single lobbyist whose name is spelled two different ways on filings may be represented twice here.
Lobbyist
Covered positions?
Melanie Nathanson Policy Analyst, Senior Policy Advisr. - Senator Bob Graham
Senior Legislative Asst. - Rep. Sander Levin
Megan Hauck Pd intern, LC, Scheduler, LA, Pol Advsr - Sen. Don Nickles
Deputy Asst. Secretary - DHHS
Special Asst. to POTUS - White House
Sr. Policy Advisor - Senator Mitch McConnell
Disclosures Filed
Once a lobbying engagement begins, the lobbyist or firm is required to file updates four times a year. Those updates sometimes change which lobbyists are involved or add new issues being discussed. When lobbyists stop working for a client, the firm is also supposed to file a report disclosing the end of the relationship.
1st Quarter, 2024
In Q1, Nathanson+Hauck lobbied for GE Healthcare , earning $60,000. The report was filed on April 3.
Original Filing: 301546412.xml
Lobbying Issues
HR 2882 - Further Consolidation Appropriations- Support for critical government programs remaining operational and available.
HR 4366 - Consolidated Appropriations Act of FY 2024 and other Extensions Act - Support for critical government programs remaining operational and available.
H.R. 7024 - Tax Relief for American Families and Workers Act of 2024 - Issues related to the R&D tax credit and other tax treatments to support job creation and innovation.
Regulations, guidance and other activity related to artificial intelligence and health care.
Regulations, guidance and other activity related to women's health care and research.
Rules and regulations regarding the availability of diagnostic treatments and testing related to neurological disorders.
S. 1544 - Facilitating Innovative Nuclear Diagnostics Act of 2023 - A bill to ensure that there is equitable and accessible coverage of radio-diagnostic treatments to detect diseases like Alzheimer's and Parkinson's across the country.
Issues related to ensuring access to real time hospital data during national emergencies and pandemics for physicians and relevant health care personnel.
Issues related to ensuring rural, underserved and other communities access to certain procedures and related drugs used to diagnose neurological disorders, such as Parkinson's disease.
Issues related to women's health specific to access to imaging and other procedures used to assess the health of breasts and other organs.
Issues related to ensuring access to cancer screening and treatments.
Agencies Lobbied
U.S. House of Representatives
4th Quarter, 2023
In Q4, Nathanson+Hauck lobbied for GE Healthcare , earning $60,000. The report was filed on Dec. 31, 2023.
Original Filing: 301521039.xml
Lobbying Issues
HR 6363 - Further Continuing Appropriations and other Extenders Act - Support for critical government programs remaining operational and available.
HR 5860 - Continuing Appropriations Act of FY 2024 and other Extensions Act - Support for critical government programs remaining operational and available.
Rules and regulations regarding the availability of diagnostic treatments and testing related to neurological disorders.
S. 1544 - Facilitating Innovative Nuclear Diagnostics Act of 2023 - A bill to ensure that there is equitable and accessible coverage of radio-diagnostic treatments to detect diseases like Alzheimer's and Parkinson's across the country.
Issues related to ensuring access to real time hospital data during national emergencies and pandemics for physicians and relevant health care personnel.
Issues related to ensuring rural, underserved and other communities access to certain procedures and related drugs used to diagnose neurological disorders, such as Parkinson's disease.
Issues related to women's health specific to access to imaging and other procedures used to assess the health of breasts and other organs.
Issues related to ensuring access to cancer screening and treatments.
Agencies Lobbied
U.S. House of Representatives
3rd Quarter, 2023
In Q3, Nathanson+Hauck lobbied for GE Healthcare , earning $60,000. The report was filed on Oct. 7, 2023.
Original Filing: 301498350.xml
Lobbying Issues
Rules and regulations regarding the availability of diagnostic treatments and testing related to neurological disorders.
S. 1544 - Facilitating Innovative Nuclear Diagnostics Act of 2023 - A bill to ensure that there is equitable and accessible coverage of radio-diagnostic treatments to detect diseases like Alzheimer's and Parkinson's across the country.
Issues related to ensuring access to real time hospital data during national emergencies and pandemics for physicians and relevant health care personnel.
Issues related to ensuring rural, underserved and other communities access to certain procedures and related drugs used to diagnose neurological disorders, such as Parkinson's disease.
Issues related to women's health specific to access to imaging and other procedures used to assess the health of breasts and other organs.
Issues related to ensuring access to cancer screening and treatments.
Agencies Lobbied
U.S. House of Representatives
2nd Quarter, 2023
In Q2, Nathanson+Hauck lobbied for GE Healthcare , earning $60,000. The report was filed on July 4, 2023.
Original Filing: 301472895.xml
Lobbying Issues
S. 1544 - Facilitating Innovative Nuclear Diagnostics Act of 2023 - A bill to ensure that there is equitable and accessible coverage of radio-diagnostic treatments to detect diseases like Alzheimer's and Parkinson's across the country.
Issues related to ensuring access to real time hospital data during national emergencies and pandemics for physicians and relevant health care personnel.
Issues related to ensuring rural, underserved and other communities access to certain procedures and related drugs used to diagnose neurological disorders, such as Parkinson's disease.
Issues related to women's health specific to access to imaging and other procedures used to assess the health of breasts and other organs.
Agencies Lobbied
U.S. House of Representatives
1st Quarter, 2023
In Q1, Nathanson+Hauck lobbied for GE Healthcare , earning $60,000. The report was filed on April 11, 2023.
Original Filing: 301450509.xml
Lobbying Issues
Issues related to ensuring access to real time hospital data during national emergencies and pandemics for physicians and relevant health care personnel.
Issues related to ensuring rural, underserved and other communities access to certain procedures and related drugs used to diagnose neurological disorders, such as Parkinson's disease.
Issues related to women's health specific to access to imaging and other procedures used to assess the health of breasts and other organs.
Agencies Lobbied
U.S. House of Representatives
4th Quarter, 2022
In Q4, Nathanson+Hauck lobbied for GE Healthcare , earning $60,000. The report was filed on Jan. 2, 2023.
Original Filing: 301424597.xml
Lobbying Issues
HR 2617 - Consolidated Appropriations Act for Fiscal Year 2023 - Issues related to health care preparedness and information sharing to support real time health care decision making across the country.
H.R. 5305 - Extending Government Funding and Delivering Emergency Assistance Act. Issues related to FDA User Fee Agreements.
H.R. 7667 - The Food and Drug Amendments of 2022 Act - Issues related to FDA and Medical Devices.
S 4348 - The FDA Safety and Landmark Advancements Act - Issues related to FDA and Medical Devices.
H.R.4479/S.2609 - The FIND Act - Legislation focused on ensuring equitable access to radio pharmaceuticals.
PL 117- 2- The American Rescue Plan Act - Implementation issues related to ensuring access to technologies for the fight against COVID-19.
Issues related to ensuring that vital information regarding hospital bed availability and other key issues are made available in all states to ensure patient access and safety during disasters and emergencies.
Agencies Lobbied
U.S. House of Representatives
3rd Quarter, 2022
In Q3, Nathanson+Hauck lobbied for GE Healthcare , earning $60,000. The report was filed on Oct. 8, 2022.
Original Filing: 301401987.xml
Lobbying Issues
H.R. 5305 - Extending Government Funding and Delivering Emergency Assistance Act. Issues related to FDA User Fee Agreements.
H.R. 7667 - The Food and Drug Amendments of 2022 Act - Issues related to FDA and Medical Devices.
S 4348 - The FDA Safety and Landmark Advancements Act - Issues related to FDA and Medical Devices.
H.R.4479/S.2609 - The FIND Act - Legislation focused on ensuring equitable access to radio pharmaceuticals.
PL 117- 2- The American Rescue Plan Act - Implementation issues related to ensuring access to technologies for the fight against COVID-19.
Issues related to ensuring that vital information regarding hospital bed availability and other key issues are made available in all states to ensure patient access and safety during disasters and emergencies.
Agencies Lobbied
U.S. House of Representatives
2nd Quarter, 2022
In Q2, Nathanson+Hauck lobbied for GE Healthcare , earning $60,000. The report was filed on July 2, 2022.
Original Filing: 301377155.xml
Lobbying Issues
H.R. 7667 - The Food and Drug Amendments of 2022 Act - Issues related to FDA and Medical Devices.
S 4348 - The FDA Safety and Landmark Advancements Act - Issues related to FDA and Medical Devices.
H.R.4479/S.2609 - The FIND Act - Legislation focused on ensuring equitable access to radio pharmaceuticals.
PL 117- 2- The American Rescue Plan Act - Implementation issues related to ensuring access to technologies for the fight against COVID-19.
Issues related to ensuring that vital information regarding hospital bed availability and other key issues are made available in all states to ensure patient access and safety during disasters and emergencies.
Agencies Lobbied
U.S. House of Representatives
1st Quarter, 2022
In Q1, Nathanson+Hauck lobbied for GE Healthcare , earning $60,000. The report was filed on April 17, 2022.
Original Filing: 301357882.xml
Lobbying Issues
H.R. 2471 Consolidated Appropriations Act for FY 2022 - Issues related to CDC and ASPR's ability to support real-time health information sharing during pandemics and other emergencies.
H.R.4479/S.2609 - The FIND Act - Legislation focused on ensuring equitable access to radio pharmaceuticals.
PL 117- 2- The American Rescue Plan Act - Implementation issues related to ensuring access to technologies for the fight against COVID-19.
Issues related to ensuring that vital information regarding hospital bed availability and other key issues are made available in all states to ensure patient access and safety during disasters and emergencies.
Agencies Lobbied
U.S. House of Representatives
4th Quarter, 2021
In Q4, Nathanson+Hauck lobbied for GE Healthcare , earning $60,000. The report was filed on Jan. 7, 2022.
Original Filing: 301320570.xml
Lobbying Issues
H.R.4479/S.2609 - The FIND Act - Legislation focused on ensuring equitable access to radio pharmaceuticals.
PL 117- 2- The American Rescue Plan Act - Implementation issues related to ensuring access to technologies for the fight against COVID-19.
Issues related to ensuring that vital information regarding hospital bed availability and other key issues are made available in all states to ensure patient access and safety during disasters and emergencies.
Agencies Lobbied
U.S. House of Representatives
3rd Quarter, 2021
In Q3, Nathanson+Hauck lobbied for GE Healthcare , earning $60,000. The report was filed on Oct. 10, 2021.
Original Filing: 301297644.xml
Lobbying Issues
H.R.4479/S.2609 - The FIND Act - Legislation focused on ensuring equitable access to radio pharmaceuticals.
PL 117- 2- The American Rescue Plan Act - Implementation issues related to ensuring access to technologies for the fight against COVID-19.
Issues related to ensuring that vital information regarding hospital bed availability and other key issues are made available in all states to ensure patient access and safety during disasters and emergencies.
Agencies Lobbied
U.S. House of Representatives
2nd Quarter, 2021
In Q2, Nathanson+Hauck lobbied for GE Healthcare , earning $60,000. The report was filed on July 13, 2021.
Original Filing: 301275478.xml
Lobbying Issues
PL 117- 2- The American Rescue Plan Act - Issues related to ensuring access to technologies for the fight against COVID-19.
S. 748 - Medicare Sequester Relief Act - Issues related to allowing Medicare providers the support to continue their work during the pandemic.
Issues related to ensuring that vital information regarding hospital bed availability and other key issues are made available in all states to ensure patient access and safety during disasters and emergencies.
Issues related to payment for and access to radiopharmaceuticals.
Agencies Lobbied
U.S. House of Representatives
1st Quarter, 2021
In Q1, Nathanson+Hauck lobbied for GE Healthcare , earning $60,000. The report was filed on April 11, 2021.
Original Filing: 301251641.xml
Lobbying Issues
PL 117- 2- The American Rescue Plan Act - Issues related to ensuring access to technologies for the fight against COVID-19.
S. 748 - Medicare Sequester Relief Act - Issues related to allowing Medicare providers the support to continue their work during the pandemic.
Issues related to ensuring that vital information regarding hospital bed availability and other key issues are made available in all states to ensure patient access and safety during disasters and emergencies.
Issues related to payment for and access to radiopharmaceuticals.
Agencies Lobbied
U.S. House of Representatives
4th Quarter, 2020
In Q4, Nathanson+Hauck lobbied for GE Healthcare , earning $60,000. The report was filed on Jan. 6, 2021.
Original Filing: 301228998.xml
Lobbying Issues
PL 116-260/H.R. 133- Consolidated Appropriations Act of 2021 - Issues related to Medicare Provider support and relief and Covid-19 relief and response.
Issues related to ensuring access and appropriate reimbursement of radiopharmaceuticals in the Medicare program
Work with the Administration to ensure that national equipment needs are met to fight the disease and care for patients.
Agencies Lobbied
U.S. House of Representatives
3rd Quarter, 2020
In Q3, Nathanson+Hauck lobbied for GE Healthcare , earning $60,000. The report was filed on Oct. 11, 2020.
Original Filing: 301208674.xml
Lobbying Issues
H.R. 8406 - The HEROES Act (Modified) - Issues supporting providers and patients to access technology and equipment needed to fight against the coronavirus.
H.R. 8319 - Continuing Appropriations Act of 2021 - Ensuring that vital programs covered by HHS, the VA and other agencies continue.
H.R. 6800 - The HEROES Act - Issues related to data collection and work to ensure that states and localities have the tools necessary to manage spikes in COVID-19 in their communities.
The Senate HEALS Act (bill number not available) - Issues supporting providers and patients to access technology and equipment needed to fight against the coronavirus.
Issues related to ensuring access and appropriate reimbursement of radiopharmaceuticals in the Medicare program
Work with the Administration to ensure that national equipment needs are met to fight the disease and care for patients.
Agencies Lobbied
U.S. House of Representatives
2nd Quarter, 2020
In Q2, Nathanson+Hauck lobbied for GE Healthcare , earning $60,000. The report was filed on July 3, 2020.
Original Filing: 301185256.xml
Lobbying Issues
H.R. 6800 - The HEROES Act - Issues related to data collection and work to ensure that states and localities have the tools necessary to manage spikes in COVID-19 in their communities.
H.R. 748 - CARES Act - Issues related to supporting the national work fighting COVID-19 and increasing capacity for needed equipment.
H.R. 6201 - Families First Coronavirus Response Act - Issues related to ensuring that the federal government is best supporting programs to allow states and localities to best support and equip hospitals and health care providers fight COVID-19.
H.R. 6074 - Coronavirus Preparedness and Response Supplemental Appropriations Act of 2020 - Issues related to supporting programs and institutions supporting during the current pandemic.
Executive actions impacting children's health care including potential regulations designed to restructure the Medicaid program.
Work with the Administration to ensure that national equipment needs are met to fight the disease and care for patients.
Agencies Lobbied
U.S. House of Representatives
1st Quarter, 2020
In Q1, Nathanson+Hauck lobbied for GE Healthcare , earning $60,000. The report was filed on April 8, 2020.
Original Filing: 301154528.xml
Lobbying Issues
H.R. 748 - CARES Act - Issues related to supporting the national work fighting COVID-19 and increasing capacity for needed equipment.
H.R. 6201 - Families First Coronavirus Response Act - Issues related to ensuring that the federal government is best supporting programs to allow states and localities to best support and equip hospitals and health care providers fight COVID-19.
H.R. 6074 - Coronavirus Preparedness and Response Supplemental Appropriations Act of 2020 - Issues related to supporting programs and institutions supporting during the current pandemic.
Executive actions impacting children's health care including potential regulations designed to restructure the Medicaid program.
Work with the Administration to ensure that national equipment needs are met to fight the disease and care for patients.
Agencies Lobbied
U.S. House of Representatives
4th Quarter, 2019
In Q4, Nathanson+Hauck lobbied for GE Healthcare , earning $20,000. The report was filed on Jan. 7, 2020.
Original Filing: 301103687.xml
Lobbying Issues
H.R. 1865 - Further Consolidated Appropriations Bill for FY 2020- policies focused on device tax and new technologies for the diagnosis and potential treatment of Alzheimer's disease.
Agencies Lobbied
U.S. House of Representatives
3rd Quarter, 2019
In Q3, Nathanson+Hauck lobbied for GE Healthcare , earning $20,000. The report was filed on Oct. 13, 2019.
Original Filing: 301064904.xml
Lobbying Issues
Issues related to the ACA device tax.
Issues related to ensuring that approved devices, scans and tests for patients with Alzheimer's disease are available and affordable for Americans.
Agencies Lobbied
U.S. House of Representatives
3rd Quarter, 2019
Nathanson+Hauck filed a lobbying registration on Sept. 24, 2019 to represent GE Healthcare, effective Sept. 2, 2019.
Original Filing: 301062359.xml
Issue(s) they said they’d lobby about: Issues related to the ability to maintain, create and advance healthcare technologies in the United States. .
1st Quarter, 2014
Nathanson+Hauck terminated an engagement in which they represented General Electric Company on Jan. 7, 2014.
Original Filing: 300611791.xml
4th Quarter, 2013
In Q4, Nathanson+Hauck lobbied for General Electric Company , earning $50,000. The report was filed on Jan. 9, 2014.
Original Filing: 300612233.xml
Lobbying Issues
H.R. 8- American Taxpayer Relief Act of 2012 - focused on provisions in the law related to imaging and devices.
Issues related to new policies regarding Medicare's coding of molecular diagnostic testing
S. Con. Res. 8 - Senate Budget Resolution - Focus on policies impacting Medicare and Medicaid programs as well as taxes and the treatment of medical devices.President's Budget for FY2014 - Issues related to devices, imaging and clinical laboratories included in the President's budget document.
S. 232 - Medical Device Access and Innovation Protection Act - Issues related to the medical device tax as promulgated in the ACA.
Medicare regulations related to the reimbursement of certain diagnostic tests form clinical laboratories.
HJ Res 59 - Continuing Resolution for FY 2014 - Focused on the status of a repeal or delay of the device tax.
Amendment to HJ Res 59 - Bipartisan Budget Act of 2013 - Language related to repeal or delay of the device tax.
SGR Repeal and Medicare Beneficiary Access Improvement Act of 2013 - Focus on issues that could impact HIT, EHRs, Imaging and other related issues.
Agencies Lobbied
U.S. House of Representatives
Lobbying Issues
H. R. 933 - Consolidation and Further Continuing Appropriations Act of 2013 - issues related to health care-based appropriationsH.R. 523 Protect Medical Innovation Act of 2013
Regulations supporting the implementation of the health reform law and ARRA related to advancing health information technology, EMRs, and imaging.
Issues regarding regulations and payment structures for clinical laboratories.
H.R. 8- American Taxpayer Relief Act of 2012 - focused on provisions in the law related to imaging and devices.
H.R. 6014 - Katie Sepich Enhanced DNA Collection Act of 2012 - Focused on the need for better support of law enforcement's access to DNA technology and successfully getting it included in H.R. 8 which passed into law on January 1, 2013 and the impact of the Supreme Court ruling on DNA testing.
Medicare regulations related to the reimbursement of certain diagnostic tests form clinical laboratories.
S. 232 - Medical Device Access and Innovation Protection Act - Issues related to the medical device tax as promulgated in the ACA.
HJ Res 59 - Continuing Resolution for FY 2014 - Focused on the status of a repeal or delay of the device tax.
H.R. 3204 - Drug Quality and Security Act - Legislation to address securing the pharmaceutical supply chain and drug compounding practices in the United States.
Amendment to HJ Res 59 - Bipartisan Budget Act of 2013 - Language related to repeal or delay of the device tax.
SGR Repeal and Medicare Beneficiary Access Improvement Act of 2013 - Focus on issues that could impact HIT, EHRs, Imaging and other related issues.
CMS regulations related to certain coding issues.
Agencies Lobbied
U.S. House of Representatives
3rd Quarter, 2013
In Q3, Nathanson+Hauck lobbied for General Electric Company , earning $50,000. The report was filed on Oct. 16, 2013.
Original Filing: 300594695.xml
Lobbying Issues
H.R. 8- American Taxpayer Relief Act of 2012 - focused on provisions in the law related to imaging and devices.
Issues related to new policies regarding Medicare's coding of molecular diagnostic testing
S. Con. Res. 8 - Senate Budget Resolution - Focus on policies impacting Medicare and Medicaid programs as well as taxes and the treatment of medical devices.President's Budget for FY2014 - Issues related to devices, imaging and clinical laboratories included in the President's budget document.
S. 232 - Medical Device Access and Innovation Protection Act - Issues related to the medical device tax as promulgated in the ACA.
Medicare regulations related to the reimbursement of certain diagnostic tests form clinical laboratories.
HJ Res 59 - Continuing Resolution for FY 2014 - Focused on the status of a repeal or delay of the device tax.
Agencies Lobbied
U.S. House of Representatives
Lobbying Issues
H.R. 527 - Responsible Helium Stewardship Act of 2013 - Focus on ensuring that the nation's helium supply is adequate for the purposes of supporting certain medical scans.
H. R. 933 - Consolidation and Further Continuing Appropriations Act of 2013 - issues related to health care-based appropriationsH.R. 523 Protect Medical Innovation Act of 2013
Regulations supporting the implementation of the health reform law and ARRA related to advancing health information technology, EMRs, and imaging.
Federal guidance and regulations regarding the development of Accountable Care Organizations and the Physician Payment Sunshine Act.
Issues regarding regulations and payment structures for clinical laboratories.
H.R. 8- American Taxpayer Relief Act of 2012 - focused on provisions in the law related to imaging and devices.
H.R. 6014 - Katie Sepich Enhanced DNA Collection Act of 2012 - Focused on the need for better support of law enforcement's access to DNA technology and successfully getting it included in H.R. 8 which passed into law on January 1, 2013 and the impact of the Supreme Court ruling on DNA testing.
Medicare regulations related to the reimbursement of certain diagnostic tests form clinical laboratories.
S. 232 - Medical Device Access and Innovation Protection Act - Issues related to the medical device tax as promulgated in the ACA.
HJ Res 59 - Continuing Resolution for FY 2014 - Focused on the status of a repeal or delay of the device tax.
H.R. 3204 - Drug Quality and Security Act - Legislation to address securing the pharmaceutical supply chain and drug compounding practices in the United States.
Agencies Lobbied
U.S. House of Representatives
2nd Quarter, 2013
In Q2, Nathanson+Hauck lobbied for General Electric Company , earning $50,000. The report was filed on July 17, 2013.
Original Filing: 300574112.xml
Lobbying Issues
H.R. 8- American Taxpayer Relief Act of 2012 - focused on provisions in the law related to imaging and devices.
Issues related to new policies regarding Medicare's coding of molecular diagnostic testing
S. Con. Res. 8 - Senate Budget Resolution - Focus on policies impacting Medicare and Medicaid programs as well as taxes and the treatment of medical devices.President's Budget for FY2014 - Issues related to devices, imaging and clinical laboratories included in the President's budget document.
Medicare regulations related to the reimbursement of certain diagnostic tests form clinical laboratories.
Agencies Lobbied
U.S. House of Representatives
Lobbying Issues
H.R. 527 - Responsible Helium Stewardship Act of 2013 - Focus on ensuring that the nation's helium supply is adequate for the purposes of supporting certain medical scans.
H. R. 933 - Consolidation and Further Continuing Appropriations Act of 2013 - issues related to health care-based appropriationsS. 232 Medicare Device Access and Innovation Protection Act
H.R. 523 Protect Medical Innovation Act of 2013
Regulations supporting the implementation of the health reform law and ARRA related to advancing health information technology, EMRs, and imaging.
Federal guidance and regulations regarding the development of Accountable Care Organizations and the Physician Payment Sunshine Act.
Issues regarding regulations and payment structures for clinical laboratories.
H.R. 8- American Taxpayer Relief Act of 2012 - focused on provisions in the law related to imaging and devices.
H.R. 6014 - Katie Sepich Enhanced DNA Collection Act of 2012 - Focused on the need for better support of law enforcement's access to DNA technology and successfully getting it included in H.R. 8 which passed into law on January 1, 2013 and the impact of the Supreme Court ruling on DNA testing.
Medicare regulations related to the reimbursement of certain diagnostic tests form clinical laboratories.
Agencies Lobbied
U.S. House of Representatives
1st Quarter, 2013
In Q1, Nathanson+Hauck lobbied for General Electric Company , earning $50,000. The report was filed on April 16, 2013.
Original Filing: 300551050.xml
Lobbying Issues
H.R. 8- American Taxpayer Relief Act of 2012 - focused on provisions in the law related to imaging and devices.
Issues related to new policies regarding Medicare's coding of molecular diagnostic testing
S. Con. Res. 8 - Senate Budget Resolution - Focus on policies impacting Medicare and Medicaid programs as well as taxes and the treatment of medical devices.President's Budget for FY2014 - Issues related to devices, imaging and clinical laboratories included in the President's budget document.
Agencies Lobbied
U.S. House of Representatives
Lobbying Issues
H.R. 527 - Responsible Helium Stewardship Act of 2013 - Focus on ensuring that the nation's helium supply is adequate for the purposes of supporting certain medical scans.
H. R. 933 - Consolidation and Further Continuing Appropriations Act of 2013 - issues related to health care-based appropriationsS. 232 Medicare Device Access and Innovation Protection Act
H.R. 523 Protect Medical Innovation Act of 2013
Regulations supporting the implementation of the health reform law and ARRA related to advancing health information technology, EMRs, and imaging.
Federal guidance and regulations regarding the development of Accountable Care Organizations and the Physician Payment Sunshine Act.
Issues regarding regulations and payment structures for clinical laboratories.
H.R. 8- American Taxpayer Relief Act of 2012 - focused on provisions in the law related to imaging and devices.
H.R. 6014 - Katie Sepich Enhanced DNA Collection Act of 2012 - Focused on the need for better support of law enforcement's access to DNA technology and successfully getting it included in H.R. 8 which passed into law on January 1, 2013
Agencies Lobbied
U.S. House of Representatives
4th Quarter, 2012
In Q4, Nathanson+Hauck lobbied for General Electric Company , earning $50,000. The report was filed on Jan. 10, 2013.
Original Filing: 300527088.xml
Lobbying Issues
S. 1096- The Preservation of Access to Osteoporosis Testing for Medicare Beneficiaries Act and related Medicare issues
H.R. 8- American Taxpayer Relief Act of 2012 - focused on provisions related to imaging and devices.
PL 112-25- Budget Control Act of 2011. Monitoring Medicare proposals impacting imaging, screening, and health information technology.
Agencies Lobbied
U.S. House of Representatives
Lobbying Issues
S. 2374 - Helium Stewardship Act of 2012 - Focus on ensuring that the nation's helium supply is adequate for the purposes of supporting certain medical scans.
PL 112-25- Budget Control Act of 2011. Monitoring Medicare proposals impacting imaging, screening, and health information technology.S. 3187 - the FDA Safety and Innovation Act of 2012- work on issues regarding medical devices included in the device section of the user fee bill.
Regulations supporting the implementation of the health reform law and ARRA related to advancing health information technology, EMRs, and imaging.
Federal guidance and regulations regarding the development of Accountable Care Organizations and the Physician Payment Sunshine Act.
Issues regarding regulations and payment structures for clinical laboratories.
Work on raising osteoporosis awareness, education, detection and prevention issues.
Legislative and regulatory efforts related to the repeal or delay of the device tax.
H.R. 8- American Taxpayer Relief Act of 2012 - focused on provisions related to imaging and devices.
H.R. 6014 - Katie Sepich Enhanced DNA Collection Act of 2012 - Focused on the need for better support of law enforcement's access to DNA technology.
Agencies Lobbied
U.S. House of Representatives
3rd Quarter, 2012
In Q3, Nathanson+Hauck lobbied for General Electric Company , earning $50,000. The report was filed on Oct. 17, 2012.
Original Filing: 300509211.xml
Lobbying Issues
S. 1096- The Preservation of Access to Osteoporosis Testing for Medicare Beneficiaries Act and related Medicare issues
Agencies Lobbied
U.S. House of Representatives
Lobbying Issues
S. 2374 - Helium Stewardship Act of 2012 - Focus on ensuring that the nation's helium supply is adequate for the purposes of supporting certain medical scans.
PL 112-25- Budget Control Act of 2011. Monitoring Medicare proposals impacting imaging, screening, and health information technology.S. 3187 - the FDA Safety and Innovation Act of 2012- work on issues regarding medical devices included in the device section of the user fee bill.
Regulations supporting the implementation of the health reform law and ARRA related to advancing health information technology, EMRs, and imaging.
Federal guidance and regulations regarding the development of Accountable Care Organizations and the Physician Payment Sunshine Act.
Issues regarding regulations and payment structures for clinical laboratories.
Work on raising osteoporosis awareness, education, detection and prevention issues.
Legislative and regulatory efforts related to the repeal or delay of the device tax.
Agencies Lobbied
U.S. House of Representatives
2nd Quarter, 2012
In Q2, Nathanson+Hauck lobbied for General Electric Company , earning $50,000. The report was filed on July 5, 2012.
Original Filing: 300480968.xml
Lobbying Issues
S. 1096- The Preservation of Access to Osteoporosis Testing for Medicare Beneficiaries Act and related Medicare issues
Agencies Lobbied
U.S. House of Representatives
Lobbying Issues
S. 2374 - Helium Stewardship Act of 2012 - Focus on ensuring that the nation's helium supply is adequate for the purposes of supporting certain medical scans.
PL 112-25- Budget Control Act of 2011. Monitoring Medicare proposals impacting imaging, screening, and health information technology.S. 3187 - the FDA Safety and Innovation Act of 2012- work on issues regarding medical devices included in the device section of the user fee bill.
Regulations supporting the implementation of the health reform law and ARRA related to advancing health information technology, EMRs, and imaging.
Federal guidance and regulations regarding the development of Accountable Care Organizations and the Physician Payment Sunshine Act.
Issues regarding regulations and payment structures for clinical laboratories.
Work on raising osteoporosis awareness, education, detection and prevention issues.
Agencies Lobbied
U.S. House of Representatives
1st Quarter, 2012
In Q1, Nathanson+Hauck lobbied for General Electric Company , earning $45,000. The report was filed on April 11, 2012.
Original Filing: 300458920.xml
Lobbying Issues
H.R. 3630 (S. Amdt. 1465) - Temporary Payroll Tax Cut Continuation Act of 2011-2012- Focus on the inclusion of provisions supporting Osteoporosis screening and pathology reimbursement rates.
S. 1096- The Preservation of Access to Osteoporosis Testing for Medicare Beneficiaries Act and related Medicare issues
Agencies Lobbied
U.S. House of Representatives
Lobbying Issues
H.R. 3630 (S. Amdt. 1465) - Temporary Payroll Tax Cut Continuation Act of 2011-2012- Focus on the inclusion of provisions supporting Osteoporosis screening and pathology reimbursement rates.
PL 112-25- Budget Control Act of 2011. Monitoring Medicare proposals impacting imaging, screening, and health information technology.Regulations supporting the implementation of the health reform law and ARRA related to advancing health information technology, EMRs, and imaging.
Federal guidance and regulations regarding the development of Accountable Care Organizations and the Physician Payment Sunshine Act.
Issues regarding regulations and payment structures for clinical laboratories.
Work on raising osteoporosis awareness, education, detection and prevention issues.
Work on raising awareness on the serious shortage of Helium and its impact on healthcare.
Agencies Lobbied
U.S. House of Representatives
4th Quarter, 2011
In Q4, Nathanson+Hauck lobbied for General Electric Company , earning $45,000. The report was filed on Dec. 27, 2011.
Original Filing: 300433837.xml
Lobbying Issues
H.R. 3630 (S. Amdt. 1465) - Temporary Payroll Tax Cut Continuation Act of 2011- Focus on the inclusion of provisions supporting Osteoporosis screening and pathology reimbursement rates.
S. 1096- The Preservation of Access to Osteoporosis Testing for Medicare Beneficiaries Act of 2011 and related Medicare issues.Public Law 112-25 - The Budget Control Act of 2011 - Monitoring Medicare provisions impacting imaging, screenings, and health information technology.
S. 1096 - The Preservation of Access to Osteoporosis Testing for Medicare Beneficiaries Act and related issues regarding Medicare
Agencies Lobbied
U.S. House of Representatives
Lobbying Issues
H.R. 3630 (S. Amdt. 1465) - Temporary Payroll Tax Cut Continuation Act of 2011- Focus on the inclusion of provisions supporting Osteoporosis screening and pathology reimbursement rates.
PL 112-25- Budget Control Act of 2011. Monitoring Medicare proposals impacting imaging, screening, and health information technology.Regulations supporting the implementation of the health reform law and ARRA related to advancing health information technology, EMRs, and imaging.
Federal guidance and regulations regarding the development of Accountable Care Organizations and the Physician Payment Sunshine Act.
Issues regarding regulations and payment structures for clinical laboratories.
Work on raising osteoporosis awareness, education, detection and prevention issues.
Agencies Lobbied
U.S. House of Representatives
3rd Quarter, 2011
In Q3, Nathanson+Hauck lobbied for General Electric Company , earning $45,000. The report was filed on Oct. 10, 2011.
Original Filing: 300411710.xml
Lobbying Issues
Public Law 112-25 - The Budget Control Act of 2011 - Monitoring Medicare provisions impacting imaging, screenings, and health information technology.
S. 1096 - The Preservation of Access to Osteoporosis Testing for Medicare Beneficiaries Act and related issues regarding Medicare ...payments and policies for osteoporosis-related scans.
Agencies Lobbied
U.S. House of Representatives
Lobbying Issues
Public Law 112-25- Budget Control Act of 2011. Monitoring Medicare provisions impacting imaging, screening, and health information technology.
S. 223 - FAA Air Transportation, Modernization and Safety Improvement Act - specifically provisions related to using spectrum for...new hospitals technologies.
Regulations supporting the implementation of the health reform law and ARRA related to advancing health information technology, EMRs and imaging.
Federal guidance and regulations regarding the development of Accountable Care Organizations.
Issues regarding regulations and payment structures for clinical laboratories.
Work on raising osteoporosis awareness, education, detection and prevention issues.
Agencies Lobbied
U.S. House of Representatives
2nd Quarter, 2011
In Q2, Nathanson+Hauck lobbied for General Electric Company , earning $45,000. The report was filed on July 12, 2011.
Original Filing: 300388428.xml
Lobbying Issues
S. 223- FAA Air Transportation, Modernization and Safety Improvement Act, specifically to provisions related to using spectrum for new hospital technologies.
Regulations supporting the implementation of health reform law and ARRA related to supporting health information technology, Cont.
electronic medical records and imaging.
Federal guidance and regulations regarding the development of Accountable Care Organizations.
Issues regarding regulations and payment structures for clinical laboratories.
Work on raising osteoporosis awareness, education, detection and prevention issues.
Agencies Lobbied
U.S. House of Representatives
Lobbying Issues
S. 1096- the Preservation of Access to Osteoporosis Testing for Medicare Beneficiaries Act of 2011 and related issues regarding Medicare payment for related scans.
Agencies Lobbied
U.S. House of Representatives
1st Quarter, 2011
In Q1, Nathanson+Hauck lobbied for General Electric Company , earning $30,600. The report was filed on April 1, 2011.
Original Filing: 300359718.xml
Lobbying Issues
Provisions in the Health Reform Law and ARRA supporting health information technology, electronic medical records and imaging. Federal regulations regarding Accountable Care Organizations. Senate FAA Reauthorization bill provision related to using spectrum for new hospital-based technologies.
Agencies Lobbied
U.S. House of Representatives
Lobbying Issues
Health Reform Law Regulations related to Accountable Care Organizations. Provision in the Health Reform Law related to Medicare payments for bone density scans (DEXA).
Agencies Lobbied
U.S. Senate
1st Quarter, 2011
Nathanson+Hauck filed a lobbying registration on Feb. 8, 2011 to represent General Electric Company, effective Jan. 21, 2011.
Original Filing: 300357756.xml
Issue(s) they said they’d lobby about: Issues related to health information technology, payment issues related to public and private insurance, health care quality and related issues encompassed in the implementation of the health reform law. .
Source: Clerk of the U.S. House of Representatives and Secretary of the Senate
Searching...